Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Valvular Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 196 articles: HTML format

Single Articles

September 2022
1. TEN BERG J, Rocca B, Angiolillo DJ, Hayashida K, et al
   The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties.
   Eur Heart J. 2022 Sep 21. pii: 6708420. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. XIA J, Xue Y, Ma X
   A rare case of native aortic valve thrombosis after radiofrequency ablation.
   Eur Heart J. 2022 Sep 16. pii: 6701788. doi: 10.1093.
   PubMed    
   
   
   
3. HAN Y
   Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement.
   Eur Heart J. 2022 Sep 14. pii: 6697004. doi: 10.1093.
   PubMed    
   
   
   August 2022
4. KRONENBERG F, Mora S, Stroes ESG, Ference BA, et al
   Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
   Eur Heart J. 2022 Aug 29. pii: 6670882. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. ZHANG X, Wang H, Guo Y, Peng Y, et al
   Aortic root 'sink down' caused mitral stenosis after aortic valve replacement: a rare presentation of Bechet's disease.
   Eur Heart J. 2022 Aug 18. pii: 6670978. doi: 10.1093.
   PubMed    
   
   
   
6. KRONENBERG F
   Lipoprotein(a) and aortic valve stenosis: work in progress.
   Eur Heart J. 2022 Aug 18. pii: 6670979. doi: 10.1093.
   PubMed    
   
   
   
7. WENZEL P
   Thromboinflammation in cardiovascular disease: lessons learned for the management of hypertension, heart failure, and aortic valve stenosis.
   Eur Heart J. 2022 Aug 18. pii: 6671020. doi: 10.1093.
   PubMed    
   
   
   
8. 
   Corrigendum to: Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
   Eur Heart J. 2022 Aug 3. pii: 6653544. doi: 10.1093.
   PubMed    
   
   
   
9. CREA F
   Challenges in the management of aortic stenosis, multiple valve disease, culture-negative endocarditis, and cardiac surgery during pregnancy.
   Eur Heart J. 2022;43:2715-2719.
   PubMed    
   
   
   
10. HAHN RT, Pibarot P, Otto CM
    Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.
    Eur Heart J. 2022;43:2767-2769.
    PubMed    
    
    
    
11. ANDREOTTI F, Massetti M, Ten Berg J
    Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS.
    Eur Heart J. 2022;43:2798-2800.
    PubMed    
    
    
    
12. ZHAO ZG, Chen F, Wei X, Feng Y, et al
    Transcatheter mitral valve implantation in severely calcified rheumatic mitral stenosis without annular calcification.
    Eur Heart J. 2022 Aug 1. pii: 6652910. doi: 10.1093.
    PubMed    
    
    
    July 2022
13. KAISER Y, van der Toorn JE, Singh SS, Zheng KH, et al
    Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification.
    Eur Heart J. 2022 Jul 23. pii: 6649081. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. PARALE C, Ahmed AS, Bhardwaj A
    Isolated posterior mitral leaflet elongation-related dynamic left ventricular outflow obstruction.
    Eur Heart J. 2022;43:2713.
    PubMed    
    
    
    
15. BHARDWAJ A, Pillai AA, Balaguru S
    A case of hypoplastic posterior mitral leaflet-related severe mitral regurgitation associated with ostium secundum atrial septal defect.
    Eur Heart J. 2022 Jul 21. pii: 6647914. doi: 10.1093.
    PubMed    
    
    
    
16. BAJAJ A, Cuchel M
    From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?
    Eur Heart J. 2022 Jul 13. pii: 6641994. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. BELANGER AM, Akioyamen LE, Ruel I, Hales L, et al
    Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century.
    Eur Heart J. 2022 Jul 1. pii: 6625868. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2022
18. VERGALLO R, Volpe M
    The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis.
    Eur Heart J. 2022 Jun 25. pii: 6617779. doi: 10.1093.
    PubMed    
    
    
    
19. 
    Corrigendum to: Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2022 Jun 18. pii: 6611060. doi: 10.1093.
    PubMed    
    
    
    
20. WEI X, Zhou M, Chen Y, Chen M, et al
    Paroxysmal massive mitral regurgitation.
    Eur Heart J. 2022 Jun 17. pii: 6609956. doi: 10.1093.
    PubMed    
    
    
    
21. HAN Y
    Current clinical data and experience of TAVR in China.
    Eur Heart J. 2022;43:2087-2088.
    PubMed    
    
    
    
22. BELLUSCHI I, Buzzatti N, Denti P, Maisano F, et al
    Transcatheter lithotripsy to facilitate post-dilatation of underexpanded aortic transcatheter heart valve.
    Eur Heart J. 2022;43:2081.
    PubMed    
    
    
    
23. 
    Corrigendum to: Transcatheter repair of persistent tricuspid regurgitation after MitraClip with the TriCinch system: interventional valve treatment toward the surgical standard.
    Eur Heart J. 2022 Jun 1. pii: 6596482. doi: 10.1093.
    PubMed    
    
    
    
24. 
    Corrigendum to: Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation.
    Eur Heart J. 2022 Jun 1. pii: 6596481. doi: 10.1093.
    PubMed    
    
    
    May 2022
25. 
    Corrigendum to: The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 May 19. pii: 6588540. doi: 10.1093.
    PubMed    
    
    
    
26. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022;43:1884.
    PubMed    
    
    
    
28. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022;43:1792-1793.
    PubMed    
    
    
    
29. WILSON J, Muthumala A, Khanji MY
    Complete resolution of apical hypertrophy and fibrosis: the role of serial cardiovascular magnetic resonance tissue characterization to differentiate hypertrophic cardiomyopathy from myocarditis.
    Eur Heart J. 2022;43:1774.
    PubMed    
    
    
    
30. TRIBOUILLOY C, Bohbot Y, Kubala M, Ruschitzka F, et al
    Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2022 May 2. pii: 6576528. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. CREA F
    Valvular heart disease: the quest for new pharmacological targets.
    Eur Heart J. 2022;43:1601-1604.
    PubMed    
    
    
    
32. BEDEIR K, Robichaux RP, Gleason TG
    Surgical whole valve embolization 15 years after implantation.
    Eur Heart J. 2022;43:1685.
    PubMed    
    
    
    
33. JANG SJ, Chen YH, Shen TC
    Pitfalls in recapture or repositioning of Evolut system using cusp overlap technique.
    Eur Heart J. 2022;43:1684.
    PubMed    
    
    
    April 2022
34. WINDECKER S, Okuno T, Unbehaun A, Mack M, et al
    Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
    Eur Heart J. 2022 Apr 25. pii: 6572863. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. DAYAN V, Gomes WJ
    The new ESC/EACTS recommendations for transcatheter aortic valve implantation go too far.
    Eur Heart J. 2022 Apr 25. pii: 6572861. doi: 10.1093.
    PubMed    
    
    
    
36. THIELE H, Collet JP, Leon M, Mehran R, et al
    The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 Apr 25. pii: 6572862. doi: 10.1093.
    PubMed    
    
    
    
37. CALCAGNO S, Di Pietro R, Biondi-Zoccai G, Versaci F, et al
    Cerebral protection device out of transcatheter heart procedures: a bridge to surgery.
    Eur Heart J. 2022;43:1598.
    PubMed    
    
    
    March 2022
38. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022 Mar 10. pii: 6546148. doi: 10.1093.
    PubMed    
    
    
    
39. TRENKWALDER T, Krane M
    Mitral valve prolapse: will genetics finally solve the puzzle?
    Eur Heart J. 2022 Mar 10. pii: 6546010. doi: 10.1093.
    PubMed    
    
    
    
40. ROSELLI C, Yu M, Nauffal V, Georges A, et al
    Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.
    Eur Heart J. 2022 Mar 4. pii: 6542554. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2022
41. KRALER S, Garg V, Akhmedov A
    Calcific aortic valve disease: novel insights into nitric oxide signalling.
    Eur Heart J. 2022 Feb 21. pii: 6533232. doi: 10.1093.
    PubMed    
    
    
    
42. RUDOLPH V
    Heart and kidney: towards an integrated approach to secondary mitral regurgitation.
    Eur Heart J. 2022 Feb 18. pii: 6530471. doi: 10.1093.
    PubMed    
    
    
    
43. 
    Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thorac
    Eur Heart J. 2022 Feb 18. pii: 6533332. doi: 10.1093.
    PubMed    
    
    
    
44. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022 Feb 16. pii: 6531943. doi: 10.1093.
    PubMed    
    
    
    
45. SCHMIADY MO, Carrel T, Sigler M, Eildermann K, et al
    Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup.
    Eur Heart J. 2022 Feb 15. pii: 6528555. doi: 10.1093.
    PubMed    
    
    
    
46. CREA F
    A comprehensive update on valvular heart disease: from mechanisms to Guidelines.
    Eur Heart J. 2022;43:545-549.
    PubMed    
    
    
    
47. COLOMBO A, Maisano F
    A new tool for the forgotten valve: a score to predict the risk of surgery.
    Eur Heart J. 2022;43:663-665.
    PubMed    
    
    
    
48. PAUL JF, Lansac E, Chambon E, Neuvillers L, et al
    Aortic jet lesion: new insights with multimodal imaging.
    Eur Heart J. 2022;43:543.
    PubMed    
    
    
    
49. LIU Z, Dong N, Hui H, Wang Y, et al
    Endothelial cell-derived tetrahydrobiopterin prevents aortic valve calcification.
    Eur Heart J. 2022 Feb 9. pii: 6525632. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. IUNG B, Urena M
    New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly?
    Eur Heart J. 2022;0.
    PubMed    
    
    
    
51. BEOHAR N, Ailawadi G, Kotinkaduwa LN, Redfors B, et al
    Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.
    Eur Heart J. 2022 Feb 3. pii: 6521532. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2022
52. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
    Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2022 Jan 28. pii: 6516865. doi: 10.1093.
    PubMed    
    
    
    
54. VOLPE M, Liuzzo G
    VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?
    Eur Heart J. 2022;43:181-182.
    PubMed    
    
    
    
55. BAUMGARTNER H, Iung B, Messika-Zeitoun D, Otto CM, et al
    The year in cardiovascular medicine 2021: valvular heart disease.
    Eur Heart J. 2022 Jan 3. pii: 6491394. doi: 10.1093.
    PubMed    
    
    
    December 2021
56. WEERASEKARE JM, Geske JB
    'Heart within a heart': echocardiographic assessment of hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:4775.
    PubMed    
    
    
    November 2021
57. BAUMGARTNER H
    Aortic stenosis management in 2021: better teaming up than fighting between specialties.
    Eur Heart J. 2021 Nov 28. pii: 6445126. doi: 10.1093.
    PubMed    
    
    
    
58. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
    Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
    Eur Heart J. 2021 Nov 25. pii: 6439994. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. KRALER S, Blaser MC, Aikawa E, Camici GG, et al
    Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.
    Eur Heart J. 2021 Nov 25. pii: 6440005. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
60. DREYFUS J, Audureau E, Bohbot Y, Coisne A, et al
    TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.
    Eur Heart J. 2021 Sep 29. pii: 6377884. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. CHEN QQ, Ma G, Liu JF, Cai YY, et al
    Neuraminidase 1 is a driver of experimental cardiac hypertrophy.
    Eur Heart J. 2021;42:3770-3782.
    PubMed     Abstract available
    
    
    
62. RAMAKUMAR V, Gupta A, Goswami KC, Jagia P, et al
    Mitral valvular nodules of acute rheumatic fever masquerading as intracardiac mass.
    Eur Heart J. 2021 Sep 16. pii: 6371300. doi: 10.1093.
    PubMed    
    
    
    
63. VAHANIAN A, Praz F, Milojevic M, Beyersdorf F, et al
    The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease.
    Eur Heart J. 2021 Sep 16. pii: 6371303. doi: 10.1093.
    PubMed    
    
    
    
64. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. MESSIKA-ZEITOUN D, Hibbert B, Chan V
    'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
    Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
    PubMed    
    
    
    August 2021
66. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
    Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
    Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. VAHANIAN A, Beyersdorf F, Praz F, Milojevic M, et al
    2021 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2021 Aug 28. pii: 6358470. doi: 10.1093.
    PubMed    
    
    
    
68. LOPES LR, Garcia-Hernandez S, Lorenzini M, Futema M, et al
    Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:3063-3073.
    PubMed     Abstract available
    
    
    
69. WALSH R, Bezzina CR
    ALPK3: a full spectrum cardiomyopathy gene?
    Eur Heart J. 2021;42:3074-3077.
    PubMed    
    
    
    
70. LAURI FM, Fernandez-Golfin C, Zamorano JL, Sanchez-Recalde A, et al
    Coronary compression caused by extrinsic adventitial damage: case of an early complication of trans-catheter tricuspid annuloplasty with cardioband device.
    Eur Heart J. 2021 Aug 18. pii: 6354189. doi: 10.1093.
    PubMed    
    
    
    
71. BRAUNWALD E
    Reflections on Hypertrophic Cardiomyopathy.
    Eur Heart J. 2021;42:2969-2970.
    PubMed    
    
    
    
72. TEN BERG J
    Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation.
    Eur Heart J. 2021 Aug 9. pii: 6346754. doi: 10.1093.
    PubMed    
    
    
    
73. DANGAS G, Nicolas J, Mehran R
    Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data.
    Eur Heart J. 2021 Aug 9. pii: 6346755. doi: 10.1093.
    PubMed    
    
    
    
74. CREA F
    The new frontiers in valvular heart disease: from artificial intelligence to new pharmacological targets in aortic stenosis.
    Eur Heart J. 2021;42:2871-2875.
    PubMed    
    
    
    
75. GHAREBAGHI N, Mehdizade H, Askari B, Mirza-Aghazadeh-Attari M, et al
    A bizarre foreign object in the heart: toothpick lodged in the tricuspid valve.
    Eur Heart J. 2021;42:2957.
    PubMed    
    
    
    July 2021
76. TAMARGO J, Agewall S
    Fluoroquinolone use and valvular heart disease: is the jury still out?
    Eur Heart J. 2021 Jul 13. pii: 6319851. doi: 10.1093.
    PubMed    
    
    
    
77. STRANGE JE, Holt A, Blanche P, Gislason G, et al
    Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study.
    Eur Heart J. 2021 Jul 10. pii: 6318706. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. OYETUNJI SO, Otto CM
    Transcatheter aortic valve implantation or replacement? Valve durability in the context of patient life expectancy.
    Eur Heart J. 2021 Jul 1. pii: 6311995. doi: 10.1093.
    PubMed    
    
    
    June 2021
79. ROGERS MA, Aikawa E
    Unbiased omics identifies mechanistic regulators of calcific aortic valve disease.
    Eur Heart J. 2021 Jun 28. pii: 6310290. doi: 10.1093.
    PubMed    
    
    
    
80. JORGENSEN TH, Thyregod HGH, Ihlemann N, Nissen H, et al
    Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.
    Eur Heart J. 2021 Jun 28. pii: 6310288. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. WANG Y, Han D, Zhou T, Chen C, et al
    DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells.
    Eur Heart J. 2021 Jun 28. pii: 6310285. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. XIE Y, Fang L, Li H, Xie M, et al
    Multimodality cardiac imaging for guidance of transapical transcatheter aortic valve implantation and mitral paravalvular leak closure.
    Eur Heart J. 2021 Jun 25. pii: 6309732. doi: 10.1093.
    PubMed    
    
    
    
83. MALAGOLI A, Chiusolo S, Tondi S
    Isolated double-orifice mitral valve: an atypical morphology in adult patient.
    Eur Heart J. 2021 Jun 21. pii: 6307143. doi: 10.1093.
    PubMed    
    
    
    
84. GOLIASCH G, Lang IM
    Impact of sex on the management and outcome of aortic stenosis patients: a female aortic valve stenosis paradox, and a call for personalized treatments?
    Eur Heart J. 2021 Jun 13. pii: 6297824. doi: 10.1093.
    PubMed    
    
    
    
85. VINNAKOTA S, Jentzer JC, Luis SA
    Thrombolysis for COVID-19-associated bioprosthetic mitral valve thrombosis with shock.
    Eur Heart J. 2021 Jun 11. pii: 6296967. doi: 10.1093.
    PubMed    
    
    
    
86. CREA F
    Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
    Eur Heart J. 2021;42:2137-2140.
    PubMed    
    
    
    May 2021
87. BIENJONETTI-BOUDREAU D, Fleury MA, Voisine M, Paquin A, et al
    Impact of sex on the management and outcome of aortic stenosis patients.
    Eur Heart J. 2021 May 23. pii: 6282426. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. KASKI JP
    Childhood-onset hypertrophic cardiomyopathy research coming of age.
    Eur Heart J. 2021;42:1997-1999.
    PubMed    
    
    
    
89. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    PubMed     Abstract available
    
    
    
90. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. CALIGIURI G, Franck G
    Hitting the right channels to spread a 'no-restenosis' message to vascular wall cells.
    Eur Heart J. 2021;42:1786-1788.
    PubMed    
    
    
    April 2021
92. GENEREUX P, Piazza N, Alu MC, Nazif T, et al
    Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.
    Eur Heart J. 2021 Apr 19. pii: 6237954. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. TEN BERG J, Sibbing D, Rocca B, Van Belle E, et al
    Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in coll
    Eur Heart J. 2021 Apr 5. pii: 6210683. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2021
94. CREA F
    Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation.
    Eur Heart J. 2021;42:1185-1189.
    PubMed    
    
    
    
95. COHEN-SHELLY M, Attia ZI, Friedman PA, Ito S, et al
    Electrocardiogram screening for aortic valve stenosis using artificial intelligence.
    Eur Heart J. 2021 Mar 22. pii: 6179522. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. COATS AJS, Anker SD, Baumbach A, Alfieri O, et al
    The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and
    Eur Heart J. 2021 Mar 18. pii: 6174642. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. DIBIE A, Landolff Q, Veugeois A, Amabile N, et al
    Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion.
    Eur Heart J. 2021;42:1051.
    PubMed    
    
    
    February 2021
98. CASE BC, Ben-Dor I, Satler LF, Waksman R, et al
    Rescue alcohol septal ablation for dynamic left ventricular outflow tract obstruction and haemodynamic collapse after transcatheter aortic valve implantation.
    Eur Heart J. 2021 Feb 21. pii: 6145857. doi: 10.1093.
    PubMed    
    
    
    
99. CREA F
    New guidelines on adult congenital heart disease, the fantastic four in the treatment of heart failure, and also what happened in the last year in heart failure and valvular heart disease.
    Eur Heart J. 2021;42:551-554.
    PubMed    
    
    
    
100. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
     Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
     Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2021
101. KRONENBERG F
     Aortic valve stenosis: the long and winding road.
     Eur Heart J. 2021 Jan 31. pii: 6124840. doi: 10.1093/eurheartj/ehaa1069.
     PubMed    
     
     
     
102. QUERCIOLI A, Capettini AC, Gherli R, Secco GG, et al
     Three-dimensional echo guidance of percutaneous mitral paravalvular leak closure.
     Eur Heart J. 2021;42:359.
     PubMed    
     
     
     
103. GOPALAMURUGAN AB, Anantharaman R, Abubacker M, Varshaa GM, et al
     First-in-man proof of feasibility: PCI, TAVR, and TEVAR of aortic arch with a hybrid approach through a trans-caval (cavo-aortic) access in the same procedure.
     Eur Heart J. 2021;42:357.
     PubMed    
     
     
     
104. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
     Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
     Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
     PubMed     Abstract available
     
     
     
105. GALIUTO L, Patrono C
     Rivaroxaban, a novel option for patients with atrial fibrillation and a bioprosthetic mitral valve.
     Eur Heart J. 2021 Jan 4. pii: 6062729. doi: 10.1093/eurheartj/ehaa1075.
     PubMed    
     
     
     
106. BERMEJO J, Postigo A, Baumgartner H
     The year in cardiovascular medicine 2020: valvular heart disease.
     Eur Heart J. 2021 Jan 3. pii: 6060050. doi: 10.1093/eurheartj/ehaa1060.
     PubMed    
     
     
     
107. NICHOLLS M
     The Year in Cardiovascular Medicine 2020: Valvular Heart Disease.
     Eur Heart J. 2021 Jan 3. pii: 6060073. doi: 10.1093/eurheartj/ehaa1024.
     PubMed    
     
     
     December 2020
108. QIAN H, Li Y, Qin Y, Huang H, et al
     An unusual left ventricle pseudo-aneurysm with progressive mitral regurgitation.
     Eur Heart J. 2020 Dec 31. pii: 6056658. doi: 10.1093/eurheartj/ehaa1076.
     PubMed    
     
     
     
109. CHEN J, Wei L, Wang C
     The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery.
     Eur Heart J. 2020 Dec 12. pii: 6031686. doi: 10.1093.
     PubMed    
     
     
     
110. VERMEERSCH G, Prihadi E, De Keulenaer G, Vermeersch P, et al
     Giant native aortic valve thrombus under non-vitamin K antagonist oral anticoagulant: first manifestation of antiphospholipid syndrome.
     Eur Heart J. 2020 Dec 11. pii: 6030876. doi: 10.1093.
     PubMed    
     
     
     
111. AKAZAWA Y, Higaki T, Moritani T, Yamaguchi O, et al
     Acute mitral valve occlusion caused by atrial septal defect occluder.
     Eur Heart J. 2020 Dec 11. pii: 6031437. doi: 10.1093.
     PubMed    
     
     
     
112. CREA F
     Challenges in risk stratification of symptomatic and asymptomatic valvular heart disease: lessons from large observational studies.
     Eur Heart J. 2020;41:4289-4292.
     PubMed    
     
     
     
113. TOTH E, Dancy L, Amin-Youssef G, Papachristidis A, et al
     Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient.
     Eur Heart J. 2020;41:4365.
     PubMed    
     
     
     November 2020
114. HAHN RT
     Degenerative mitral stenosis: interpreting the meaning of mean gradient.
     Eur Heart J. 2020 Nov 30. pii: 6010480. doi: 10.1093.
     PubMed    
     
     
     
115. BERTRAND PB, Churchill TW, Yucel E, Namasivayam M, et al
     Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction.
     Eur Heart J. 2020 Nov 22. pii: 5998318. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. SONG L, Jin J, Ma X, Xu M, et al
     Aortic dissection and rupture in a 3-year-old boy with bicuspid aortic valve.
     Eur Heart J. 2020 Nov 17. pii: 5986680. doi: 10.1093.
     PubMed    
     
     
     
117. REID A, Blanke P, Bax JJ, Leipsic J, et al
     Multimodality imaging in valvular heart disease: how to use state-of-the-art technology in daily practice.
     Eur Heart J. 2020 Nov 13. pii: 5981494. doi: 10.1093.
     PubMed     Abstract available
     
     
     
118. WATANABE M, Miyachi H, Uchiyama S, Shimizu W, et al
     Thickening of the sinus of Valsalva wall and aortic valve leaflet in a case of Takayasu's arteritis.
     Eur Heart J. 2020 Nov 12. pii: 5979511. doi: 10.1093.
     PubMed    
     
     
     
119. ALIZADEHASL A, Salehi P, Roudbari S, Peighambari MM, et al
     Infectious endocarditis of the prosthetic mitral valve after COVID-19 infection.
     Eur Heart J. 2020 Nov 7. pii: 5960182. doi: 10.1093.
     PubMed    
     
     
     
120. GALIUTO L, Patrono C
     New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trial.
     Eur Heart J. 2020;41:4089-4090.
     PubMed    
     
     
     
121. SHARMA A, Bertog S, Mbai M
     Transcatheter aortic valve lithotripsy in severely calcified bicuspid aortic stenosis prior to transcatheter aortic valve implantation.
     Eur Heart J. 2020 Nov 6. pii: 5959818. doi: 10.1093.
     PubMed    
     
     
     October 2020
122. IDRIS A, Smith Ii RL, Ryan WH, Wang Z, et al
     Primary malignant fibrous histiocytoma of the mitral valve as a rare incidental finding.
     Eur Heart J. 2020 Oct 17. pii: 5927542. doi: 10.1093.
     PubMed    
     
     
     
123. SWEDA R, Berger D, Heverhagen JT, Hunziker L, et al
     Pulmonary haemorrhage on veno-arterial ECMO: consequences of missed aortic valve regurgitation.
     Eur Heart J. 2020 Oct 14. pii: 5922864. doi: 10.1093.
     PubMed    
     
     
     September 2020
124. DELGADO V, Ajmone Marsan N, Bax JJ
     The difficult decision of when and in whom to perform isolated tricuspid valve surgery.
     Eur Heart J. 2020 Sep 27. pii: 5912178. doi: 10.1093.
     PubMed    
     
     
     
125. VALLABHAJOSYULA S, Said SM, Kitzmann AS, Michelena HI, et al
     Accelerated extensive mitral valve calcification in a young end-stage kidney disease patient.
     Eur Heart J. 2020 Sep 27. pii: 5912177. doi: 10.1093.
     PubMed    
     
     
     
126. GARBI M, Lancellotti P
     Heart Valve Specialist Core Syllabus of the ESC Council on Valvular Heart Disease.
     Eur Heart J. 2020 Sep 25. pii: 5911420. doi: 10.1093.
     PubMed    
     
     
     
127. DREYFUS J, Flagiello M, Bazire B, Eggenspieler F, et al
     Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes.
     Eur Heart J. 2020 Sep 25. pii: 5911419. doi: 10.1093.
     PubMed     Abstract available
     
     
     
128. BAUMGARTNER H
     The new European Heart Journal Valvular Heart Disease Team.
     Eur Heart J. 2020 Sep 15. pii: 5906089. doi: 10.1093.
     PubMed    
     
     
     
129. BAUMGARTNER H, Iung B, Otto CM
     Timing of intervention in asymptomatic patients with valvular heart disease.
     Eur Heart J. 2020 Sep 9. pii: 5903163. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. NG ACT, Holmes DR, Mack MJ, Delgado V, et al
     Leaflet immobility and thrombosis in transcatheter aortic valve replacement.
     Eur Heart J. 2020;41:3184-3197.
     PubMed     Abstract available
     
     
     August 2020
131. TARANTINI G, Cardaioli F, Pavei A, Fabris T, et al
     Unfolding of unexpected and extreme transcatheter aortic valve distortion.
     Eur Heart J. 2020 Aug 18. pii: 5893662. doi: 10.1093.
     PubMed    
     
     
     
132. FERLINI M, Mauri S
     Variable rate of stroke after transcatheter aortic valve replacement with self-expandable valves: more doubts than certainties.
     Eur Heart J. 2020 Aug 18. pii: 5893661. doi: 10.1093.
     PubMed    
     
     
     
133. THIELE H, Abdel-Wahab M, Desch S
     Stroke rates after transcatheter aortic valve replacement: does valve choice play a role?
     Eur Heart J. 2020 Aug 18. pii: 5893660. doi: 10.1093.
     PubMed    
     
     
     
134. MARONA M, Celinska-Spodar M, Spiewak M, Konopka A, et al
     Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.
     Eur Heart J. 2020;41:2921.
     PubMed    
     
     
     
135. MOHTY D, Pibarot P, Damy T
     Aortic stenosis and amyloid heart disease: 'the 2A dangerous liaisons'.
     Eur Heart J. 2020;41:2815.
     PubMed    
     
     
     
136. MATSUSHITA K, Hess S, Ohlmann P, Morel O, et al
     Accordion phenomenon in the descending aorta during transcatheter aortic valve replacement followed by mesenteric ischaemia.
     Eur Heart J. 2020;41:2819.
     PubMed    
     
     
     
137. LUSCHER TF
     Frontiers in valvular heart disease: outcomes of novel percutaneous procedures.
     Eur Heart J. 2020;41:2717-2720.
     PubMed    
     
     
     July 2020
138. BEIRAS-FERNANDEZ A, Ruf TF, Obadia JI, Munzel T, et al
     Neochord anterior leaflet treatment to facilitate transcatheter mitral valve replacement with 3D real-time echocardiography.
     Eur Heart J. 2020 Jul 29. pii: 5877565. doi: 10.1093.
     PubMed    
     
     
     
139. KALRA DK, Arora A, Kavinsky C
     A gigantic right atrium due to tricuspid valve dysfunction.
     Eur Heart J. 2020 Jul 29. pii: 5877567. doi: 10.1093.
     PubMed    
     
     
     
140. HIRJI S, Zogg CK, Kaneko T
     The utility of the nationwide readmissions database in understanding contemporary transcatheter aortic valve replacement outcomes.
     Eur Heart J. 2020 Jul 17. pii: 5873282. doi: 10.1093.
     PubMed    
     
     
     
141. NAZIR S, Ahuja KR, Alamir MA
     Is the national readmission database the right database to identify valve-in-valve transcatheter aortic valve replacement patients?
     Eur Heart J. 2020 Jul 17. pii: 5873284. doi: 10.1093.
     PubMed    
     
     
     
142. FALK RH, Dorbala S
     Transthyretin cardiac amyloidosis in patients with severe aortic stenosis.
     Eur Heart J. 2020 Jul 8. pii: 5868579. doi: 10.1093.
     PubMed    
     
     
     
143. NAZARZADEH M, Rahimi K
     Mendelian randomization of plasma lipids and aortic valve stenosis: the importance of outlier variants and population stratification.
     Eur Heart J. 2020 Jul 6. pii: 5867643. doi: 10.1093.
     PubMed    
     
     
     June 2020
144. ROMMEL KP, Lurz P
     Transcatheter tricuspid valve repair and pulmonary hypertension: navigating through troubled waters.
     Eur Heart J. 2020 Jun 30. pii: 5865477. doi: 10.1093.
     PubMed    
     
     
     
145. JIANG Q, Chen M
     Assessing causality in associations of lipid levels with aortic valve stenosis.
     Eur Heart J. 2020 Jun 30. pii: 5865472. doi: 10.1093.
     PubMed    
     
     
     
146. D'ALTO M, Naeije R
     Transcatheter tricuspid valve repair in patients with pulmonary hypertension.
     Eur Heart J. 2020 Jun 30. pii: 5865473. doi: 10.1093.
     PubMed    
     
     
     
147. BLEIZIFFER S, Simonato M, Webb JG, Rodes-Cabau J, et al
     Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.
     Eur Heart J. 2020 Jun 27. pii: 5863929. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. VARGA A, Hegele RA
     Triglyceride-rich particles: new actors in valvular aortic stenosis.
     Eur Heart J. 2020;41:2300-2303.
     PubMed    
     
     
     
149. IUNG B, Wendler O
     Valve-in-valve vs. repeat surgical aortic valve replacement: a new match but the game is not over!
     Eur Heart J. 2020 Jun 12. pii: 5856871. doi: 10.1093.
     PubMed    
     
     
     
150. VARELA-CANCELO A, Salgado-Fernandez J, Calvino-Santos R, Bouzas-Zubeldia B, et al
     Successful transfemoral management of transcatheter aortic valve embolization into left ventricle.
     Eur Heart J. 2020 Jun 4. pii: 5851539. doi: 10.1093.
     PubMed    
     
     
     May 2020
151. HIRJI SA, Percy ED, Zogg CK, Malarczyk A, et al
     Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes.
     Eur Heart J. 2020 May 23. pii: 5841644. doi: 10.1093.
     PubMed     Abstract available
     
     
     
152. LUSCHER TF
     From TAVI to tricuspid cliping: fine-tuning the management of valvular heart disease.
     Eur Heart J. 2020;41:1863-1866.
     PubMed    
     
     
     
153. NAZARZADEH M, Rahimi K
     Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects.
     Eur Heart J. 2020;41:1942.
     PubMed    
     
     
     
154. NICKENIG G, Vogelhuber J
     The tricuspid tragedy: from Cinderella to celebrity.
     Eur Heart J. 2020;41:1930-1931.
     PubMed    
     
     
     
155. WEBB J, Wood D, Sathananthan J, Landes U, et al
     Balloon-expandable or self-expandable transcatheter heart valves. Which are best?
     Eur Heart J. 2020;41:1900-1902.
     PubMed    
     
     
     
156. GREVE AM
     High low-density lipoprotein levels and high risk of aortic stenosis.
     Eur Heart J. 2020 May 7. pii: 5831945. doi: 10.1093.
     PubMed    
     
     
     April 2020
157. NIENABER CA, Yuan X
     Lipid levels linked to symptomatic aortic valve stenosis: evidence from Mendelian randomization?
     Eur Heart J. 2020 Apr 29. pii: 5827054. doi: 10.1093.
     PubMed    
     
     
     
158. FERNANDEZ GASSO L, Jimenez Lopez-Guarch C, Garcia Robles JA, Solis J, et al
     Double-orifice mitral valve associated with multivalvular involvement: a new entity?
     Eur Heart J. 2020 Apr 26. pii: 5825474. doi: 10.1093.
     PubMed    
     
     
     
159. COLOMBIER S, Alexe R, Tapponnier M, Delay D, et al
     45 years of prosthetic mitro-aortic valve technology in a single heart.
     Eur Heart J. 2020 Apr 26. pii: 5825472. doi: 10.1093.
     PubMed    
     
     
     
160. CHEN Y, Waksman R, Satler L, Barnett C, et al
     Percutaneous transcatheter release of stuck mechanical mitral valve leaflet.
     Eur Heart J. 2020 Apr 20. pii: 5822833. doi: 10.1093.
     PubMed    
     
     
     
161. ESSAYAGH B, Antoine C, Benfari G, Maalouf J, et al
     Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival.
     Eur Heart J. 2020 Apr 16. pii: 5821042. doi: 10.1093.
     PubMed     Abstract available
     
     
     
162. LI Y, Ji P, Qian H, Rao L, et al
     A rare anomaly: truncus arteriosus or pulmonary atresia.
     Eur Heart J. 2020 Apr 15. pii: 5820563. doi: 10.1093.
     PubMed    
     
     
     
163. NIETO-ROCA L, Tomas-Mallebrera M, Aldamiz-Echevarria Del Castillo G
     "King size" asymptomatic aortic aneurysm after bicuspid aortic valve surgery.
     Eur Heart J. 2020 Apr 14. pii: 5819671. doi: 10.1093.
     PubMed    
     
     
     
164. MURAKAMI T, Ohno Y, Nakazawa G, Ikari Y, et al
     Transjugular intracardiac echocardiography-guided transcatheter aortic valve implantation.
     Eur Heart J. 2020 Apr 14. pii: 5819673. doi: 10.1093.
     PubMed    
     
     
     
165. KALTOFT M, Langsted A, Nordestgaard BG
     Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study.
     Eur Heart J. 2020 Apr 8. pii: 5817922. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. SCULLY PR, Patel KP, Treibel TA, Thornton GD, et al
     Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.
     Eur Heart J. 2020 Apr 8. pii: 5817909. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2020
167. KONG WKF, Bax JJ, Delgado V
     Left ventricular myocardial fibrosis: a marker of bad prognosis in symptomatic severe aortic stenosis.
     Eur Heart J. 2020 Mar 24. pii: 5811373. doi: 10.1093.
     PubMed    
     
     
     
168. LURZ P, Orban M, Besler C, Braun D, et al
     Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair.
     Eur Heart J. 2020 Mar 16. pii: 5807655. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. HAHN RT
     Finding concordance in discord: the value of discordant invasive and echocardiographic pulmonary artery pressure measurements with severe tricuspid regurgitation.
     Eur Heart J. 2020 Mar 16. pii: 5807654. doi: 10.1093.
     PubMed    
     
     
     
170. ALVAREZ-COVARRUBIAS HA, Xhepa E, Michel JM, Kasel AM, et al
     1000 mm2 plus aortic annulus: successful treatment of a giant bicuspid aortic valve with a Sapien 3 transcatheter heart valve.
     Eur Heart J. 2020 Mar 10. pii: 5802606. doi: 10.1093.
     PubMed    
     
     
     
171. SCHMIADY MO, Taramasso M, Maisano F, Sigler M, et al
     Mitral valve surgery after MitraClip(R) implantation: what histopathology can tell us?
     Eur Heart J. 2020 Mar 6. pii: 5788531. doi: 10.1093.
     PubMed    
     
     
     
172. PARR CJ, Kass M, Yamashita MH, Jassal DS, et al
     Thrombosis of a mechanical mitral valve: a sticky situation.
     Eur Heart J. 2020 Mar 4. pii: 5780423. doi: 10.1093.
     PubMed    
     
     
     February 2020
173. JERING KS, Pfeffer MA
     From practice changing to hypothesis generating: a virtuous cycle.
     Eur Heart J. 2020;41:955-957.
     PubMed    
     
     
     
174. LUSCHER TF
     Valvular heart disease: improved procedural success and prediction of outcomes.
     Eur Heart J. 2020;41:899-902.
     PubMed    
     
     
     
175. KHOR L, Simmons LA, Von Bardeleben RS, Ng MK, et al
     Transcatheter edge-to-edge repair for tricuspid regurgitation in Barlow-type tricuspid valve prolapse.
     Eur Heart J. 2020 Feb 20. pii: 5741384. doi: 10.1093.
     PubMed    
     
     
     
176. NAZARZADEH M, Pinho-Gomes AC, Bidel Z, Dehghan A, et al
     Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.
     Eur Heart J. 2020 Feb 20. pii: 5740546. doi: 10.1093.
     PubMed     Abstract available
     
     
     
177. THIELE H, Kurz T, Feistritzer HJ, Stachel G, et al
     Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial.
     Eur Heart J. 2020 Feb 12. pii: 5734668. doi: 10.1093.
     PubMed     Abstract available
     
     
     
178. PULS M, Beuthner BE, Topci R, Vogelgesang A, et al
     Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis.
     Eur Heart J. 2020 Feb 12. pii: 5734676. doi: 10.1093.
     PubMed     Abstract available
     
     
     
179. HAMM CW, Beyersdorf F
     GARY-The Largest Registry of Aortic Stenosis Treatment Worldwide.
     Eur Heart J. 2020;41:733-735.
     PubMed    
     
     
     January 2020
180. AUFFRET V, Puri R, Leurent G, Le Breton H, et al
     Conduction disturbances following trancatheter aortic valve implantation: increasing the 'pace' towards prospective evidence.
     Eur Heart J. 2020 Jan 20. pii: 5710689. doi: 10.1093.
     PubMed    
     
     
     
181. SONDERGAARD L
     Durability of transcatheter bioprosthetic aortic valves.
     Eur Heart J. 2020 Jan 6. pii: 5697053. doi: 10.1093.
     PubMed    
     
     
     
182. RUBATTU S, Volpe M
     BNP level and post-transcatheter aortic valve replacement outcome: an intriguing J-shaped relationship.
     Eur Heart J. 2020 Jan 6. pii: 5697062. doi: 10.1093.
     PubMed    
     
     
     
183. TESTA L, Latib A, Brambilla N, De Marco F, et al
     Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis.
     Eur Heart J. 2020 Jan 6. pii: 5697056. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. BINDER RK, Dweck M, Prendergast B
     The year in cardiology: valvular heart disease.
     Eur Heart J. 2020 Jan 6. pii: 5694320. doi: 10.1093.
     PubMed    
     
     
     
185. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
     Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
     Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2019
186. CHEN S, Redfors B, O'Neill BP, Clavel MA, et al
     Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
     Eur Heart J. 2019 Dec 28. pii: 5688929. doi: 10.1093.
     PubMed     Abstract available
     
     
     
187. SIA CH, Gochuico CFS, Ong CC, Teo LL, et al
     A man with end-stage renal failure and uncontrolled hyperparathyroidism with repeat transcatheter aortic valve replacement in a surgical bioprosthetic aortic valve while avoiding patient-prosthesis mismatch.
     Eur Heart J. 2019 Dec 22. pii: 5684840. doi: 10.1093.
     PubMed    
     
     
     
188. YERASI C, O'Donoghue S, Satler LF, Waksman R, et al
     Apple Watch detecting high-grade block after transcatheter aortic valve implantation.
     Eur Heart J. 2019 Dec 3. pii: 5651110. doi: 10.1093.
     PubMed    
     
     
     November 2019
189. EBERHARD M, Hermann M, Stahli BE, Manka R, et al
     Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
     Eur Heart J. 2019 Nov 25. pii: 5640488. doi: 10.1093.
     PubMed    
     
     
     
190. CHEN S, Redfors B, Nazif T, Kirtane A, et al
     Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
     Eur Heart J. 2019 Nov 11. pii: 5621355. doi: 10.1093.
     PubMed     Abstract available
     
     
     
191. RUMPF PM, Michel JM, Xhepa E, Kasel AM, et al
     Paravalvular leakage due to ring dehiscence after mitral valve-in-ring therapy: mechanisms and percutaneous treatment.
     Eur Heart J. 2019 Nov 5. pii: 5613227. doi: 10.1093.
     PubMed    
     
     
     October 2019
192. LIN AE, Libby P, Ebert BL
     A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis.
     Eur Heart J. 2019 Oct 21. pii: 5601845. doi: 10.1093.
     PubMed    
     
     
     
193. MONTEAGUDO RUIZ JM, Zamorano Gomez JL
     Endocarditis after transcatheter aortic valve implantation: a new fiend we hardly know.
     Eur Heart J. 2019 Oct 7. pii: 5583201. doi: 10.1093.
     PubMed    
     
     
     September 2019
194. ABDEL-WAHAB M, Kitamura M, Holzhey D, Thiele H, et al
     Transcatheter aortic valve implantation with a new generation mechanically expanding valve in a patient with a protruding coronary stent into the sinus of Valsalva: the 'reversed-chimney' technique.
     Eur Heart J. 2019 Sep 24. pii: 5573049. doi: 10.1093.
     PubMed    
     
     
     December 2018
195. OBOKATA M, Reddy YNV, Melenovsky V, Pislaru S, et al
     Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.
     Eur Heart J. 2018 Dec 12. pii: 5240922. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2017
196. GALIE N, Manes A, Dardi F, Palazzini M, et al
     Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease.
     Eur Heart J. 2017 Dec 27. pii: 4780182. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: